tirzepatide lawsuit update Eli Lilly sues Mochi Health and others for 'deceptive' marketing Empower GLP-1 Lawsuit Update: Legal

Many doctors suggest starting once milk production has fully ceased, but discuss timing with your healthcare provider based on your individual situation

The hepatic microenvironment reprograms the metabolism and function of immune cells, while aberrant immune responses intensify hepatic metabolic stress

our ability to prevent or contain effects of a potential cyberattack or other privacy or data security incident

Q&A: GLP-1 uses and coverage GLP-1s are a complicated subject to navigate, and health care professionals have varying opinions

Clinical trial safety data analyzed: 0.3% pancreatitis, 1.4% gallbladder events, 11.2% discontinuation